Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zoliflodacin Testicular Function Safety Study in Healthy Men
NCT07640477Phase 4Not yet recruiting
- Sponsor
- GARDP
- Start
- Oct 2026
- Primary completion
- Nov 2027
- Countries
- 2
01
Overview
A Phase 4 trial of zoliflodacin in gonorrhea, sponsored by GARDP. Planned start Oct 2026; status: not yet recruiting.
02
Drugs
zoliflodacin
03
Conditions
gonorrhea
Beyond the preview
Go deeper on NCT07640477.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07640477.